Table 2.
CSF RT-QuIC protocols and diagnostic accuracy in prion disease
PrP Substrate | Reaction buffer | Parameters | Cohort size (N)a | Sens. | Spec. | Ref. |
---|---|---|---|---|---|---|
Hu 23–231 | 0.06–0.1 g/L substrate, 15 μL seed, 500 mM NaCl | 30 s circular shaking, 30 s incubation, 2 min break, 37 °C | 18 def sCJD | 83% | [5] | |
35 def non-CJD | 100% | |||||
25 prob. sCJD | 100% | |||||
130 ctrl | 100% | |||||
16 prob. sCJD | 87% | |||||
14 ctrl | 100% | |||||
0.05 g/L substrate, 5 μL seed, 500 mM NaCl | 24 gCJD | 83% | - | [81] | ||
20 GSS | 90% | - | ||||
12 FFI | 83% | - | ||||
Ha 23–231 | 0.1 g/L substrate, 15 μl seed, 300 mM NaCl | 1 min double orbital shaking 600 rpm, 1 min rest, 42 °C | cohort 1: 56 def sCJD | 91% | [54] | |
52 ctrl | 98% | |||||
cohort 2: 67 def sCJD | 87% | |||||
52 ctrl | 100% | |||||
15/13 def/prob. sCJD | 79% | [59] | ||||
43 ctrl | 100% | |||||
179/97/29 def/prob./pos sCJD | 81% | [50] | ||||
46 gCJD | 91% | |||||
348 ctrl | 99% | |||||
24/26 def/prob. sCJD | 73% | – | [13] | |||
Ha 14–128 - Sheep 141–234 (chimera) | 0.1 g/L substrate, 15 μL seed, 170 mM NaCl | 1 min double orbital shaking, 600 rpm, 1 min rest, 42 °C | 64 def sCJD | 80% | [22] | |
39 gCJD | 100% | |||||
400 ctrl | 99% | |||||
Ha 90–231 | 0.1 g/L substrate, 15–30 μL seed, 300 mM NaCl, 0,002% SDS | 1 min double orbital shaking 700 rpm, 1 min rest, 55 °C | 10/1 def/prob. sCJD | 91% | - | [60] |
43/5 def/prob. sCJD | 96% | |||||
39 ctrl | 100% | |||||
36/68 def/prob. sCJD | 94% | [36] | ||||
64 ctrl | 100% | |||||
111 sCJD | 92% | |||||
15 gCJD | 93% | [30] | ||||
67 ctrl | 98.5% | |||||
63 sCJD, 14 ctrlb | 95% | 100% | ||||
10/12 def/prob. sCJD | 95% | [13] | ||||
17 ctrl | 100% | |||||
116/73 def/prob. sCJD | 93% | [31] | ||||
33 gCJD | 100% | |||||
100 ctrl | 100% | |||||
61/41 def/prob. sCJD | 96% | [29] | ||||
80 ctrl | 100% | |||||
439 def sCJD | 93 | [72] | ||||
31 gCJD | 97% | |||||
69 ctrl | 98.5% |
Abbreviations: Hu Human, Ha Hamster, prob Probable, pos Possible, def Definite, ctrl Controls, sens. Sensitivity, spec. Specificity, sCJD Sporadic CJD, gCJD Genetic CJD, FFI Fatal familial insomnia, GSS Gerstmann-Sträussler-Scheinker disease
aResults obtained in disease groups with an n of 9 or lower have been omitted
bProspective cohort